Bestelling invoeren
Belgium
Orders LinkContactUsLinkComponent
 

Affinity chromatography column, HiScreen™ MabSelect Xtra™

HiScreen™ MabSelect Xtra™, PP, 75 µm, 7,7×100 mm, 4,7 ml
  28-9269-76
 :   Cytiva
Affinity chromatography column, HiScreen™ MabSelect Xtra™
  28-9269-76
 :  Cytiva
Affinity chromatography column, HiScreen™ MabSelect Xtra™
Affinity chromatography column, HiScreen™ MabSelect Xtra™

HiScreen™ MabSelect Xtra™, PP, 75 µm, 7,7×100 mm, 4,7 ml

 
1 070,00 €
   
1 * 1 ST
 

HiScreen™ MabSelect Xtra™ is prepacked with MabSelect Xtra™ of 4,7 ml volume and bed height of 10 cm make HiScreen™ columns excellent tools for method optimisation, parameter screening for capture of monoclonal antibodies (MAbs), robustness testing, and convenient scale-up.

  • Easily connected in series to achieve 20 cm bed height
  • Small bed volume gives fast results and minimal sample/buffer consumption
  • Reproducible results, scalable to BioProcess columns packed with the same chromatography media using the same linear fluid velocity
  • Flow velocity <300 cm/h; the pressure over the packed bed varies depending on a range of parameters such as the characteristics of the chromatography medium and the column tubing used
  • Dynamic capacity: ~40 mg human IgG/ml medium

Process fluid velocities can be applied, since the 10 cm bed height gives enough residence time and the results can then serve as basis for linear process scale-up.

 
  • Partikelgrootte:
    75 µm
  • Capaciteit:
    4,7 ml
  • Omschrijving:
    HiScreen™ MabSelect Xtra™
  • Seq:
    01
  • Kolombehuizing:
    PP
  • Bedafmetingen:
    7,7×100 mm
  • pH-bereik:
    3 - 10
  • Cat. No.:
    28-9269-76
  • Bindingscapaciteit:
    Approx. 40 mg humanlgG/ml at 2,4 min residence time
  • Max. druk:
    3 bar
  • Opslag:
    2 to 8 °C, 20% Ethanol
Recommendations

Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".

Otherwise, you will receive generic recommendations.